NAPA, Calif., Aug. 4, 2026 /PRNewswire/ -- The Doctors Company, the nation's largest physician-owned medical malpractice insurer, today released "Dentistry Claims: August Malpractice Risk Review," the newest edition in a monthly series of specialty-focused analyses designed to support…
Research estimates improper Medicaid expansion enrollment cost federal taxpayers nearly $33 billion in 2024; findings released as Paragon President Brian Blase testifies before Senate Budget CommitteeWASHINGTON, Aug. 4, 2026 /PRNewswire/ -- Paragon Health Institute released a major new research…
SHANGHAI, Aug. 4, 2026 /PRNewswire/ -- Innogen Pharmaceuticals (HK.2591), a biopharmaceutical company dedicated to innovative drug discovery and industrialization in metabolic diseases, today announced that its Efsubaglutide alfa manufacturing facility in Suzhou has officially passed a compliance inspection…
NEWARK, Del., Aug. 3, 2026 /PRNewswire/ -- According to the latest market analysis by Future Market Insights, the global Teleradiology Market is valued at USD 10.5 billion in 2025 and is expected to reach USD 12.4 billion in 2026. The…
SAN FRANCISCO, Aug. 3, 2026 /PRNewswire/ -- AusperBio Therapeutics Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a near-commercial Biopharmaceutical company focused on developing targeted oligonucleotide therapeutics for the treatment of chronic hepatitis B (CHB) and other diseases, today announced…
LOS ANGELES, Aug. 3, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofMapLight Therapeutics, Inc. ("MapLight" or "the Company") (NASDAQ: MPLT) for…
Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy combination regimen listed on the Pharmaceutical Benefits Scheme (PBS) for adults with relapsed or refractory follicular lymphoma (R/R FL)…
MANASSAS, Va., Aug. 1, 2026 /PRNewswire/ -- As more people take a proactive approach to their health, interest in lymph system supplements continues to grow. These nutritional products are formulated to help maintain healthy lymphatic function, fluid balance…
CJR-X final rule represents a new era of value-based care at a national scale, holding all acute-care hospitals accountable for care related to joint replacements, with bold moves away from fee-for-service.SAN FRANCISCO, July 31, 2026 /PRNewswire/ -- Today,…
HANGZHOU, China, July 31, 2026 /PRNewswire/ -- CellOrigin, a biotechnology company focused on next-generation in vivo and in vitro cell therapy technologies, has announced two major progresses in both research and strategic partnership. At the 2026 ASCO Annual Meeting,…